Ripadep Plus 2 Tablets are a fixed-dose combination of Repaglinide 2 mg and Metformin 500 mg, used in the treatment of type 2 diabetes mellitus. This combination is prescribed when diet and exercise alone are not sufficient to maintain optimal blood sugar levels. Repaglinide, a meglitinide analogue, stimulates insulin release from the pancreas to control post-meal blood sugar spikes, while Metformin reduces glucose production and absorption in the body and improves insulin sensitivity. Together, they provide effective and balanced glycemic control.
Repaglinide 2 mg increases insulin secretion to manage postprandial glucose, while Metformin 500 mg reduces glucose production and improves insulin utilization, together offering comprehensive blood sugar control.
Controls Post-Meal Blood Sugar: Helps prevent sharp increases in glucose levels after meals.
Improves Fasting Glucose Levels: Supports better baseline blood sugar control.
Dual-Mechanism Action: Combines insulin secretion enhancement with improved insulin sensitivity.
Reduces Risk of Diabetic Complications: Supports long-term metabolic and vascular health.
Clinically Trusted Combination Therapy: Widely prescribed under medical supervision for type 2 diabetes.
Take the tablet exactly as prescribed by a healthcare professional, usually before meals. Regular monitoring of blood glucose levels is recommended.
May include low blood sugar, nausea, stomach upset, dizziness, or headache. Consult a healthcare provider if side effects persist or worsen.
Globus Labs brings you WHO-GMP–certified, high-quality Repaglinide 2 mg & Metformin 500 mg Tablets IP sourced from reputed pharmaceutical manufacturers. Ripadep Plus 2 is formulated to deliver safe, potent, and clinically trusted support.
Whether you’re seeking a franchise opportunity, exploring wholesale distribution, or evaluating Globus Labs for international trade, we’re here to help you build a strong, profitable partnership. Let’s discuss how we can grow together and create meaningful value for your business.